(The Center Square) – Republicans are pushing for greater access to monoclonal antibody treatments for COVID-19 after the federal government took over the distribution of such drugs last year.
Search / 65 results found Showing: 1-10 of 65
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- There are racial and ethnic disparities in receipt of monoclonal antibody (mAb) treatment among patients with COVID-19, according to research published in the Jan. 14 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- No magic bullet exists for ending the U.S. opioid crisis, but there's hopeful news for one high-risk population: Providing addiction medication in jails reduces the odds of addicts being re-arrested after their release, new research shows.
TUESDAY, Jan. 18, 2022 (HealthDay Now) -- Advanced forms of hormone therapy are very effective at keeping prostate cancer in check, but they also can double a man's risk of falling into depression, researchers have found.
MONDAY, Jan. 17, 2022 (HealthDay News) -- U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds.
This week, the U.S. Food and Drug Administration approved a new treatment for osteoarthritis in cats, marking the first time a monoclonal antibody drug has been FDA approved for treatment of animal diseases.
FRIDAY, Jan. 14, 2022 (HealthDay News) -- The severity of certain menopause symptoms is associated with worse cognitive performance among rural women, according to a study published online Jan. 10 in Menopause.
FRIDAY, Jan. 14, 2022 (HealthDay News) -- Transgender people get greater mental health benefits if they start gender-affirming hormone treatment when they're teens instead of waiting until they're adults, a new study finds.